Magnera (MAGN) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
8 Jul, 2026Executive summary
Completed the merger of Berry Global's nonwovens and hygiene films business with Glatfelter on November 4, 2024, forming Magnera, a global leader in personal care and consumer solutions with two segments: Americas and Rest of World, serving over 1,000 customers across 46 facilities and employing approximately 9,000 people.
Fiscal Q1 2025 marked Magnera's official launch, with results exceeding prior year despite FX headwinds, integration activities, and challenging market conditions.
Focused on integration, cost-saving initiatives, and delivering on synergy commitments, with a three-year plan targeting $55 million in net synergies.
Emphasized sustainability, innovation, and a broad product portfolio across personal care, consumer solutions, hygiene, healthcare, wipes, construction, and food and beverage sectors.
Operating loss increased to $22 million from $12 million year-over-year, impacted by integration costs, inventory step-up, and currency effects; net loss widened to $60 million from $8 million.
Financial highlights
Q1 2025 net sales rose 35% year-over-year to $702 million, driven by the merger and higher selling prices; Americas $420 million, Rest of World $282 million.
Adjusted EBITDA increased 8% year-over-year to $84 million, with margin up 68 basis points to 12%.
Free cash flow post-merger was $16 million for the quarter; cash and cash equivalents at quarter end were $215 million.
Basic and diluted EPS: $(1.69) (vs. $(0.25) prior year); operating margin negative due to integration and transaction costs.
Net debt to pro forma Adjusted EBITDA at quarter-end was 4x, with total net debt at $1.78 billion.
Outlook and guidance
Fiscal 2025 adjusted EBITDA guidance set at $385–$405 million, with post-merger adjusted free cash flow projected at $75–$95 million and $85 million in capital expenditures.
FY25 midpoint guidance targets 7% year-over-year comparable earnings growth.
Annual synergy realization from the GLT transaction expected to reach $55 million net of incremental standalone costs.
Focus on deleveraging, with incremental $70 million free cash flow expected for the remainder of the year.
Working capital modeled as flat for 2025.
Latest events from Magnera
- 2026 EBITDA expected to grow 9% as synergy realization and innovation drive margin expansion.MAGN
Q4 20259 Jul 2026 - Integration and innovation drive growth, with major synergies expected by 2027.MAGN
Wells Fargo Industrials & Materials Conference 20258 Jul 2026 - Adjusted EBITDA was $90M, free cash flow $73M, net sales down 3%, guidance reaffirmed.MAGN
Q2 202613 May 2026 - 2026 guidance targets EBITDA growth, debt reduction, and expansion in key nonwoven markets.MAGN
Sidoti March Small-Cap Virtual Conference18 Mar 2026 - All proposals passed, directors elected, and no shareholder questions were raised.MAGN
AGM 20269 Mar 2026 - Net sales up 13% to $792M, adjusted EBITDA up 11%, and 2026 guidance reaffirmed.MAGN
Q1 20265 Feb 2026 - Proxy covers director elections, auditor ratification, executive pay, and strong ESG focus.MAGN
Proxy filing14 Jan 2026 - Votes on directors, auditor ratification, and executive pay are set for the 2026 meeting.MAGN
Proxy filing14 Jan 2026 - Strong Q4, raised 2026 outlook, and innovation drive global growth and operational excellence.MAGN
BofA Securities Leveraged Finance Conference 20253 Dec 2025